AU2002346223A1 - Medicinal compositions - Google Patents

Medicinal compositions

Info

Publication number
AU2002346223A1
AU2002346223A1 AU2002346223A AU2002346223A AU2002346223A1 AU 2002346223 A1 AU2002346223 A1 AU 2002346223A1 AU 2002346223 A AU2002346223 A AU 2002346223A AU 2002346223 A AU2002346223 A AU 2002346223A AU 2002346223 A1 AU2002346223 A1 AU 2002346223A1
Authority
AU
Australia
Prior art keywords
medicinal compositions
medicinal
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002346223A
Other versions
AU2002346223B2 (en
Inventor
Yoko Ikeda
Kazunori Imaizumi
Taiichi Katayama
Takayuki Manabe
Masaya Tohyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Taisho Pharmaceutical Co Ltd
Original Assignee
Japan Science and Technology Agency
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2001195471A external-priority patent/JP2003012548A/en
Application filed by Japan Science and Technology Agency, Taisho Pharmaceutical Co Ltd filed Critical Japan Science and Technology Agency
Publication of AU2002346223A1 publication Critical patent/AU2002346223A1/en
Assigned to TAISHO PHARMACEUTICAL CO., LTD., JAPAN SCIENCE AND TECHNOLOGY AGENCY reassignment TAISHO PHARMACEUTICAL CO., LTD. Amend patent request/document other than specification (104) Assignors: JAPAN SCIENCE AND TECHNOLOGY CORPORATION, TAISHO PHARMACEUTICAL CO., LTD.
Application granted granted Critical
Publication of AU2002346223B2 publication Critical patent/AU2002346223B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002346223A 2001-06-27 2002-06-27 Medicinal compositions Ceased AU2002346223B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001195471A JP2003012548A (en) 2001-06-27 2001-06-27 Medicine composition
JP2001-195471 2001-06-27
PCT/JP2002/006461 WO2003002146A1 (en) 2001-06-27 2002-06-27 Medicinal compositions

Publications (2)

Publication Number Publication Date
AU2002346223A1 true AU2002346223A1 (en) 2003-05-15
AU2002346223B2 AU2002346223B2 (en) 2004-11-11

Family

ID=19033438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002346223A Ceased AU2002346223B2 (en) 2001-06-27 2002-06-27 Medicinal compositions

Country Status (8)

Country Link
US (1) US20050065102A1 (en)
EP (1) EP1413314A4 (en)
JP (2) JP2003012548A (en)
KR (1) KR20040028796A (en)
CN (1) CN1592637A (en)
AU (1) AU2002346223B2 (en)
CA (1) CA2451850A1 (en)
WO (1) WO2003002146A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048910B2 (en) 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
US8273381B1 (en) 2006-04-14 2012-09-25 Auburn University Compositions for and methods of controlling olfactory responses to odorants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646042A (en) * 1992-08-26 1997-07-08 Ribozyme Pharmaceuticals, Inc. C-myb targeted ribozymes
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
EP0876483A1 (en) * 1996-01-26 1998-11-11 HSC Research and Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
TW565611B (en) * 1996-11-08 2003-12-11 Hayashibara Biochem Lab Trehalose phosphorylase, its preparation and uses
US6057156A (en) * 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
CN1272139A (en) * 1997-10-01 2000-11-01 阿文蒂斯药物股份有限公司 Nucleic acids coding for proteins capable of interacting with presenilins
WO1999060122A1 (en) * 1998-05-21 1999-11-25 Tanabe Seiyaku Co., Ltd. Method for examining central nervous system diseases and method for screening remedies
AR020329A1 (en) * 1998-07-09 2002-05-08 Boehringer Ingelheim Pharma A SUBSTANCE, IN PARTICULAR A RIBOZIMA, IS ABLE TO INHIBIT THE PRESENILINE EXPRESSION 2, A RECOMBINATING MOLECULA OF DNA THAT CODIFY SUCH RIBOZIMA, A RECOMBINATING UNVECTOR THAT UNDERSTANDS THE CORRECTING CELL TO A RIBO BELLING ONE.
JP2000125862A (en) * 1998-10-22 2000-05-09 Mitsubishi Chemicals Corp Novel mammalian protein and polynucleotide encoding the same

Similar Documents

Publication Publication Date Title
AU2002313236A1 (en) Medicinal compositions
AU781269C (en) Pharmaceutical compositions
EP1407785A4 (en) Medicinal compositions
HK1065944A1 (en) Medicinal compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2001273919A1 (en) Pharmaceutical compositions
AU2002365093A1 (en) Therapeutic compositions
AUPR600601A0 (en) Therapeutic compositions
AU2002321808A1 (en) Dental compositions
AU2002354460A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions
AU2002346223A1 (en) Medicinal compositions
AU2001285737A1 (en) Pharmaceutical compositions
EP1413314A4 (en) Medicinal compositions
AU2002256916A1 (en) Medicinal compositions
AU2002327341A1 (en) Thrombomodulin-containing medicinal compositions
AU2002306341A1 (en) Medicinal compositions
AU2002226759A1 (en) Medicinal composition
AU2002326822A1 (en) Pro-micelle pharmaceutical compositions
AU2002100921A4 (en) Pharmaceutical composition